Prediction of breast cancer using volatile biomarkers in the breath

Breast Cancer Research and Treatment

Volumn 99, Issue 1, 2006, Pages 19-21

  Phillips, Michael ^a,b   Cataneo, Renee N ^a   Ditkoff, Beth Ann ^c   Fisher, Peter ^c   Greenberg, Joel ^a   Gunawardena, Ratnasiri ^d   Kwon, C Stephan ^d   Tietje, Olaf ^e   Wong, Cynthia ^b,d  

^a MENSSANA RESEARCH INC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d ST VINCENT S HOSPITAL   (United States)

^e SystAim GmbH   (Switzerland)

Author keywords

Breast cancer; Breath; Prediction; Volatile organic compounds

Indexed keywords

BIOLOGICAL MARKER; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; BREAST CANCER; BREATH ANALYSIS; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SAFETY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; VALIDATION STUDY;

AGE FACTORS; AGED; BIOPSY; BREAST NEOPLASMS; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; FUZZY LOGIC; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; ORGANIC CHEMICALS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33746716859     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9176-1     Document Type: Article

References (11)

1. Phillips M, Cataneo RN, Ditkoff BA, et al. Volatile markers of breast cancer in the breath. Breast J 9: 184-191, 2003
2. Phillips M, Cataneo R, Cummin A, et al. Detection of lung cancer with volatile markers in the breath. Chest 123: 2115-2123, 2003
3. Phillips M, Boehmer J, Cataneo R, et al. Prediction of heart transplant rejection with a breath test for markers of oxidative stress. Am J Cardiol 94: 1593-1594, 2004
4. Phillips M, Cataneo R, Cheema T, et al. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clinica Chimica Acta 344: 189-194, 2004
5. Phillips M: Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 247: 272-278, 1997
6. Yazdanpanah M, Luo X, Lau R, et al. Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic Biol Med 23: 870-878, 1997
7. Hamel E, Lin C, Plowman J, et al. Antitumor 2,3-dihydro-2-(aryl)-4(1H)- quinazolinone derivatives. Interactions with tubulin. Biochem Pharmacol 51: 53-59, 1996
8. Mukherjee SKV, Prasad AK, Raj HG, Bracke ME, Olsen CE, Jain SC, Parmar VS: Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg Med Chem 9: 337-345, 2001
9. Ciatto S, Del Rosselli Turco M, Burke P, et al. Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review. Br J Cancer 89: 1645-1649, 2003
10. Schneider J PG, Bitterlich N, Neu K, Velcovsky HG, Morr H, Katz N, Eigenbrodt E: Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Anticancer Res 23: 899-906, 2003
11. Modai I, Kuperman J, Goldberg I, et al. Fuzzy logic detection of medically serious suicide attempt records in major psychiatric disorders. J Nerv Ment Dis 192: 708-710, 2004